The FDA has approved a blood test to help diagnose Alzheimer's disease, and doctors explain how it works and why it can lead ...

A 19-year-old in China has been diagnosed with Alzheimer's, the youngest case ever recorded, leaving scientists puzzled about ...

People carrying at least one APOE4 allele have a higher risk of Alzheimer's disease. People who carry two alleles have the highest risk, leading some researchers to suggest that APOE4 homozygotes have ...

The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Alamar Biosciences, a company powering precision ...

Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...

A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

Adherence to a structured lifestyle intervention was nonsuperior to a self-guided intervention regarding impact on ...

Imagine being able to see the invisible-amyloid plaques, tau tangles, and metabolic changes in the living brain. This is no ...

Obesity may quietly fast-forward Alzheimer’s disease, with blood tests revealing the change years earlier than expected.

Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on ...

SynuSight Biotech has licensed 18 F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment . SHANGH ...